Study Title
89Zr-DFO-HuMab-5B1 (MVT-2163) Imaging in Pancreatic Cancer or Other CA19-9 Positive Malignancies
Study Details
Description:
The purpose of this study is to see how well the experimental imaging agent 89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find out whether PET/CT scans done with this imaging agent produce better images of cancer.
Sponsor:
Memorial Sloan Kettering Cancer Center
Government Study Link:
NCT04883775 - Click here to see study onClinicalTrials.gov